Silverarc Capital Management, LLC Next Cure, Inc. Transaction History

Silverarc Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$3.38 - $5.27 $663,112 - $1.03 Million	-196,187 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $15,113 - $19,812	3,175 Added 1.64%	196,187 $953,000
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $3.01 Million - $4.81 Million	-528,290 Reduced 73.24%	193,012 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$6.74 - $8.02 $2.94 Million - $3.5 Million	435,804 Added 152.65%	721,302 $4.86 Million
Q2 2021 Aug 16, 2021	BUY	$7.6 - $10.28 $2.17 Million - $2.93 Million	285,498 New	285,498 $2.29 Million
Q1 2021 May 18, 2021	SELL	$9.81 - $13.88 $1.28 Million - $1.8 Million	-130,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.47 - $12.43 $1.23 Million - $1.62 Million	130,000 New	130,000 $1.42 Million

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.